The Wall Street Journal: Eli Lilly, AstraZeneca scrap trials of experimental Alzheimer’s drug

Discussion in 'Market News' started by sniper-academy, Jun 13, 2018 at 8:04 AM.


Draft saved Draft deleted
  1. sniper-academy

    sniper-academy Administrator Staff Member

    Joined:
    Sep 30, 2011
    Messages:
    248,421
    Likes Received:
    5
    AstraZeneca PLC and Eli Lilly & Co. on Tuesday scrapped two late-stage trials of an experimental Alzheimer’s drug they were co-developing, the latest blow in the long quest to find a breakthrough for the memory-robbing disorder.
    [​IMG]
    [​IMG] [​IMG] [​IMG] [​IMG]

    Continue reading...
     
Loading...

Share This Page